Compounded Cosmeceutical Topical Formulations
Formulary reviewed by Benn Bluestein-Veyra, M.Sc. Organic Chemistry · Founder, ExaVeyra Sciences
Seven topical preparations built around copper tripeptide and niacinamide, supplied in 30 g jars and 30 mL serum containers for practices that dispense from the treatment room rather than a retail shelf.
Every preparation in this category shares one container generation and one dating profile, so the decision between them is a composition decision rather than a logistics one.
Supply and documentation
- Lead time
- 3 to 5 business days from order to delivery, covering both preparation and transit.
- Coverage
- licensed in 33+ states, with licensure confirmed for your destination before a first order ships
- Testing
- Endotoxin and sterility testing on every sterile batch
- Every formulary page is checked by a chemist. ExaVeyra was founded by an M.Sc. organic chemist, and specification data is verified against the source catalog rather than reproduced from a vendor sheet.
- One verified account covers biologics, 503A compounded formulations and devices, with a single account manager rather than a separate vendor relationship for each.
Available Formulations
7 preparations with 7 strength and format options, as creams and topical serums. Beyond-use dates on the label: 180 days.
What the pharmacy can prepare. This is not a dosing recommendation, and it does not indicate suitability for any patient. Beyond-use dates are assigned at compounding and printed on each label; the shortest applicable limit governs.
Cashmere Cream (GHK-Cu 3% / Niacinamide 4%)
Topical Cream
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| (GHK-Cu 3% / Niacinamide 4%) 30 g | 180 days | Up to 5 units |
GHK-Cu Biocosmetic Cream (GHK-Cu 3% / Estriol 0.003%)
Topical Cream
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| (GHK-Cu 3% / Estriol 0.3%) 30 g | 180 days | Up to 5 units |
GHK-Cu Biocosmetic Cream + SNAP-8
Topical Cream
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| (GHK-Cu 3% / Estriol 0.3% / SNAP-8 1%) 30 g | 180 days | Up to 5 units |
GHK-Cu 3% / SNAP-8 1% / Niacinamide 3% Serum
Topical
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| (GHK-Cu 3% / SNAP-8 1% / Niacinamide 3%) 30 mL | 180 days | Up to 5 units |
GHK-Cu 3% / Niacinamide 3% Firm Boost Serum
Topical
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| (GHK-Cu 3% / Niacinamide 3%) 30 mL | 180 days | Up to 5 units |
Ketoconazole 2% / Niacinamide 4%
Cream
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| (Ketoconazole 2% / Niacinamide 4%) 30 g | 180 days | Up to 5 units |
Methylene Blue 0.0064% / Estriol 0.003% Cream
Topical Cream
| Strength & size | Beyond-use date | Quantity per fill |
|---|---|---|
| (Methylene Blue 0.0064% / Estriol 0.003%) 30 g | 180 days | Up to 5 units |
Compounded topicals are not shelf cosmetics
A retail cosmetic is manufactured to a fixed formula and sold across a counter with no prescriber involved. A compounded topical looks almost identical on a shelf and is a different category of product, which is worth knowing before it reaches your dispensing workflow: the jar resembles a skincare SKU and is easy to handle like one.
The consequence shows up in inventory. A jar leaving with a patient is gone in a way a backbar tub is not, and the clock on it started when the pharmacy compounded it rather than when the lid first came off.
The two container formats
- 30 g creams, supplied in jars, covering the copper tripeptide and niacinamide combinations and the two single-purpose creams.
- 30 mL serums, supplied as a gel, where the same actives appear at different percentages in a lighter vehicle.
The cream and serum are not the same preparation in two containers. Percentages differ between them, the vehicles differ, and each is its own line item with its own lot. A practice moving a patient between formats is moving between products.
How the range is structured
Copper tripeptide is the through line, and a practice standardizing here is mostly choosing what sits alongside it. Two entries sit outside that pattern entirely and share only the vehicle and the container size. The table carries the exact composition of each; repeating those figures in prose only creates a second place for them to go stale.
Dating is uniform across the category
Every preparation here carries the same beyond-use date and the same per-fill ceiling, which is unusual in this catalog and makes ordering arithmetic simpler than it is elsewhere. Practices can plan one reorder cadence across the whole category rather than tracking each product separately.
Uniform dating also means a single stock-rotation rule works for the whole category, which is not true of the scalp solutions or the injectables. Practices carrying both should not extend this category’s cadence to those.
Backbar habits versus patient-dispensed jars
Aesthetic practices historically kept topicals as shared treatment-room stock, drawn on across appointments. A jar prepared for one named patient is dispensed rather than shared, and practices moving from retail skincare lines usually adapt the workflow within a cycle or two.
USP General Chapter 795 sets the standards for compounding quality nonsterile preparations, which is the chapter these creams and serums are prepared under, and became official on 1 November 2023. [1]
FDA notes that compounded preparations do not undergo agency premarket review, which is the substantive difference between one of these jars and a manufactured cosmetic that carries a brand claim. [2]
Sources
- USP General Chapter <795>, Pharmaceutical Compounding, Nonsterile Preparations (accessed 2026-08-09)
- FDA, Understanding the Risks of Compounded Drugs (accessed 2026-08-09)
Request the full formulary and pricing
The pages on this site list a representative selection. Verified practitioners receive the complete named formulary, current pricing, available strengths and formats, and the identity and credentials of the compounding pharmacy that prepares each preparation.
Access requires a valid NPI. Compounded formulations are prepared by our 503A pharmacy partner, a compounding pharmacy licensed by the Texas State Board of Pharmacy. We verify the number against the national registry, and our team reviews each practice before releasing the formulary, which is why pricing is not published openly: these are prescription preparations supplied to licensed practices rather than consumer products.
Already verified? Sign in to the provider portal
Compounded medications are not FDA-approved finished drug products. Preparations are dispensed against a prescription for a named patient. Nothing on this page is medical advice or a recommendation for any patient.
Frequently asked questions
- Can these be dispensed as retail skincare?
- These are dispensed to a named patient, so they sit in a different workflow from retail skincare. Most practices adapt easily, and your account manager can map it to how you dispense today.
- Is the serum a lighter version of the cream?
- They are separate preparations. The serums carry different percentages in a gel vehicle rather than the same formula thinned, so each has its own lot.
- Why is the methylene blue percentage so low?
- That is the formulation the pharmacy prepares, and the figure in the table matches the container label. We can get you the formulation rationale from the pharmacy on request.
- What documentation ships with an order?
- Lot identification on the container label, with a Certificate of Analysis available on request. Practices with their own documentation requirements should raise them at account setup so the pharmacy can confirm what it is able to supply.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved and are prepared by a licensed 503A compounding pharmacy per individual patient prescription. Formulations are supplied to NPI-verified licensed practitioners only. A Certificate of Analysis and lot documentation are available on request. Nothing on this page is medical advice, a dosing recommendation, or a statement that any formulation is suitable for a given patient.
Reviewed 2026-08-09 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry, founder, exaveyra sciences. Specifications on this page are transcribed from the pharmacy formulary and checked line by line against the source catalog.